Skip to main content
SpringerLink
Log in

Diagnosis and Clinical Features of Colorectal Cancer

  • Chapter
Colorectal Cancer

  • 351 Accesses

Abstract

Overall 5-year survival and prognosis of colorectal malignancies showed only a slight improvement (10%–20%) over the past 40–50 years [1,2]. This contrasts with the enormous advances in our knowledge of the pathogenesis of the disease [3,4], with the existence of new combined adjuvant treatments [5, 6], with the refinement of surgical techniques [7, 8], and with the evidence of lower endoscopy as an effective screening procedure [9,10].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gatta G, Capocaccia R, Sant M et al. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 2000; 47:533–8.

    Article  PubMed  CAS  Google Scholar 

  2. Gatta G, Faivre J, Capocaccia R et al. Survival of colorectal cancer patients in Europe during the period 1978–89. Eur J Cancer 1998; 34:2176–83.

    Article  PubMed  CAS  Google Scholar 

  3. Herrera L, Luna P, Villarreal JR et al. Perspectives in colorectal cancer. J Surg Oncol 1991; 2:92–103.

    Article  CAS  Google Scholar 

  4. Boland R, Sato J, Appelman HD et al. Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression. Nature Med 1995; 1:902–9.

    Article  PubMed  CAS  Google Scholar 

  5. Kane MJ Adjuvant systemic treatment for carcinoma of the colon and rectum. Semin Oncol 1991; 18:421–42.

    PubMed  CAS  Google Scholar 

  6. Kemeny N, Huang Y, Cohen AM et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999; 341:2039–48.

    Article  PubMed  CAS  Google Scholar 

  7. Heald RJ, Moran BJ, Ryall RDH et al. Rectal cancer. The Basingstoke experience of total mesorectal excision, 1978–97. Arch Surg 1998; 133:894–9.

    Article  PubMed  CAS  Google Scholar 

  8. Khalili TM, Fleshner PR, Hiatt JR et al. Colorectal cancer. Comparison of laparoscopic with open approaches. Dis Colon Rectum 1998; 41:832–8.

    Article  PubMed  CAS  Google Scholar 

  9. Winawer SJ, Zauber AG, O’Brien MJ et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med 1993;328:901–6.

    Article  PubMed  CAS  Google Scholar 

  10. Winawer SJ, Zauber AG, Nah Ho M et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993; 329:1977–81.

    Article  PubMed  CAS  Google Scholar 

  11. Gerard A, Bleiberg H Delay in diagnosis of colorectal cancer. Eur J Cancer Clin Oncol 1987; 23:1089–90.

    Article  PubMed  CAS  Google Scholar 

  12. Crerand S, Feeley TM, Waldron RP et al. Colorectal carcinoma over 30 years at one hospital: no evidence for a shift to the right. Int J Colorect Dis 1991; 6:184–7.

    Article  CAS  Google Scholar 

  13. Copeland EM, Miller LD, Jones RS Prognostic factors in carcinoma of the colon and rectum. Am J Surg 1968; 166:875–9.

    Article  Google Scholar 

  14. Ponz de Leon M, Sacchetti C, Sassatelli R et al. Cancer of the large bowel: Dukes’ staging, duration of symptoms, multiple tumours and other relevant clinical features derived from a population-based registry. Ital J Gastroenterol 1988; 20:175–9.

    Google Scholar 

  15. Jones R, Lydeard S Prevalence of symptoms of dyspepsia in the community. BMJ 1989; 298:30–2.

    Article  PubMed  CAS  Google Scholar 

  16. Thiis-Evensen E, Hoff GS, Sauar J et al. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Scand J Gastroenterol 1999; 34:414–20.

    Article  PubMed  CAS  Google Scholar 

  17. Irvin TT, Greaney MG Duration of symptoms and prognosis of carcinoma of the colon and rectum. Surg Gynecol Obstet 1977; 144:883–6.

    PubMed  CAS  Google Scholar 

  18. Holliday HW, Hardcastle JD Delay in diagnosis and treatment of symptomatic colorectal cancer. Lancet 1979; 1:309–11.

    Article  PubMed  CAS  Google Scholar 

  19. Robinson E, Mohilever J, Zidan J et al. Colorectal cancer: incidence, delay in diagnosis and stage of disease. Eur J Cancer Clin Oncol 1986; 22:157–61.

    Article  PubMed  CAS  Google Scholar 

  20. Curless R, French J, Williams GV et al. Comparison of gastrointestinal symptoms in colorectal carcinoma patients and community controls with respect to age. Gut 1994; 35:1267–70.

    Article  PubMed  CAS  Google Scholar 

  21. Winawer SJ, Zauber AG, O’Brien MJ et al. The National Polyp Study: design, methods, and characteristics of patients with newly diagnosed polyps. Cancer 1992; 70:1236–45.

    Article  PubMed  CAS  Google Scholar 

  22. O’Brien MJ, Winawe SJ, Zauber AG et al. The National Polyp Study: patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 1990; 98:371–9.

    PubMed  Google Scholar 

  23. Weisburger JH Causes, relevant mechanisms, and prevention of large bowel cancer. Semin Oncol 1991; 18:316–36.

    PubMed  CAS  Google Scholar 

  24. Faivre J, Tazi MA, El Mrini T et al. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study. Br J Cancer 1999; 79:680–3.

    Article  PubMed  CAS  Google Scholar 

  25. Kronborg O, Wahrendorf J Colorectal cancer screening: methods, benefits and costs. Colorectal cancer screening: methods, benefits and costs. Eur J Cancer 1994; 30:877–9.

    Article  Google Scholar 

  26. Allison JE, Tekawa IS, Ransom LJ et al. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996; 334:155–9.

    Article  PubMed  CAS  Google Scholar 

  27. Robinson MHE, Hardcastle JD, Moss SM et al. The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut 1999; 45:588–92.

    Article  PubMed  CAS  Google Scholar 

  28. Torosian MH The clinical usefulness and limitations of tumor markers. Surg Gynecol Obstet 1988; 166:567–79.

    PubMed  CAS  Google Scholar 

  29. Minton JP, Martin EW The use of serial CEA determinations to predict recurrence of colon cancer and when to do a second-look operation. Cancer 1978; 42:1422–7.

    Article  PubMed  CAS  Google Scholar 

  30. Wanebo H, Stearns M, Schwartz M Use of CEA as indicator of early recurrence and as guide to selected second-look procedure in patients with colorectal cancer. Ann Surg 1978; 188:481–93.

    Article  PubMed  CAS  Google Scholar 

  31. Sariego J, Byrd ME, Kerstein M et al. Changing patterns in colorectal carcinoma: a 25-year experience. Am Surg 1992; 58:686–91.

    PubMed  CAS  Google Scholar 

  32. Nazarian HK, Giuliano AE, Hiatt JR Colorectal carcinoma: analysis of management in two medical eras. J Surg Oncol 1993; 52:46–9.

    Article  PubMed  CAS  Google Scholar 

  33. Lynch HT, Watson P, Kriegler M et al. Differential diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome I and Lynch syndrome II). Dis Colon Rectum 1988; 31:372–7.

    Article  PubMed  CAS  Google Scholar 

  34. Vasen HFA, den Hartog Jager FCA, Menko FH et al. Screening for hereditary non-polyposis colorectal cancer: a study of 22 kindreds in the Netherlands. Am J Med 1989; 86:27881.

    Article  Google Scholar 

  35. Rex DK, Smith JJ, Ulbright TM et al. Distal colonic hyperplastic polyps do not predict proximal adenomas in asymptomatic average-risk subjects. Gastroenterology 1992; 102:317–9.

    PubMed  CAS  Google Scholar 

  36. Thiis-Evensen E, Hoff GS, Sauar J et al. Flexible sigmoidoscopy or colonoscopy as a screening modality for colorectal adenomas in older age groups? Findings in a cohort of the normal population aged 63–72 years. Gut 1999; 45:834–9.

    Article  PubMed  CAS  Google Scholar 

  37. Schutz SM, Lee JG, Schmitt CM et al. Clues to patient dissatisfaction with conscious sedation for colonoscopy. Am J Gastroenterol 1994; 89:1476–9.

    PubMed  CAS  Google Scholar 

  38. Lazzaroni M, Bianchi Porro G. Preparation, premedication, and surveillance. Endoscopy 1996; 28:6–12.

    Article  Google Scholar 

  39. Saunders BP, Macrae F, Williams CB What makes colonoscopy difficult? Gut 1993; 34(1).

    Article  Google Scholar 

  40. Saunders BP, Fukumoto M, Halligan S et al. Why is colonoscopy more difficult in women? Gastrointest Endosc 1996; 43:124–6.

    Article  PubMed  CAS  Google Scholar 

  41. Ott DJ, Chen YM, Gelfand DW et al. Single-contrast vs double-contrast barium enema in the detection of colonic polyps. Am J Roentgenol 1986; 146:993–6.

    CAS  Google Scholar 

  42. Neugut Al, Forde KA Screening colonoscopy: has the time come? Am J Gastroent 1988; 83:295–7.

    PubMed  CAS  Google Scholar 

  43. Fenlon HM, Nunes DP, Schroy PC et al. A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps. N Engl J Med 1999; 341:1496–503.

    Article  PubMed  CAS  Google Scholar 

  44. Schenenberger AW, Bauerfeind P, Krestin GP et al. Virtual colonoscopy with magnetic resonance imaging: in vitro evaluation of a new concept. Gastroenterology 1997; 112:1863–70.

    Article  Google Scholar 

  45. Johnson CD, Ahlquist DA Computed tomography colonography (virtual colonoscopy): a new method for colorectal screening. Gut 1999; 44:301–5.

    Article  PubMed  CAS  Google Scholar 

  46. Hara AK, Johnson CD, Reed IE et al. Detection of colorectal polyps with CT colography: initial assessment of sensitivity and specificity. Radiology. 1997; 205:59–65.

    PubMed  CAS  Google Scholar 

  47. Rex DK, Vining D, Kopecky KK An initial experience with screening for colon polyps using spiral CT with and without CT colography. Gastrointest Endosc 1999; 50:309–13.

    Article  PubMed  CAS  Google Scholar 

  48. Lanspa SJ, Rouse J, Smyrk T et al. Epidemiologic characteristics of the flat adenoma of Muto. A prospective study. Dis Colon Rectum 1992; 35:543–6.

    Article  PubMed  CAS  Google Scholar 

  49. Hara AK, Johnson CD, Reed JE et al. Reducing data size and radiation dose for CTC (CT colography). Am J Roentgenol 1997; 168:1181–4.

    CAS  Google Scholar 

  50. Limberg B Diagnosis of large bowel tumours by colonic sonography. Lancet 1990; 335:144–6.

    Article  PubMed  CAS  Google Scholar 

  51. Limberg B Diagnosis of acute ulcerative colitis and colonic Crohn’s disease by colonic sonography. J Clin Ultrasound 1989; 17:25–31.

    Article  PubMed  CAS  Google Scholar 

  52. Limberg B Diagnosis and staging of colonic tumors by conventional abdominal sonography as compared with hydrocolonic sonography. N Engl J Med 1992; 327:65–9.

    Article  PubMed  CAS  Google Scholar 

  53. Chui DW, Gooding GAW, McQuaid KR et al. Hydrocolonic ultrasonography in the detection of colonic polyps and tumors. N Engl J Med 1994; 331:1685–8.

    Article  PubMed  CAS  Google Scholar 

  54. Tempero M, Brand R, Holdeman K et al. New imaging techniques in colorectal cancer. Semin Oncol 1995; 22:448–71.

    PubMed  CAS  Google Scholar 

  55. Katsura Y, Yamada K, Ishizawa T et al. Endorectal ultrasonography for the assessment of wall invasion and lymph node metastasis in rectal cancer. Dis Colon Rectum 1992; 35:362–8.

    Article  PubMed  CAS  Google Scholar 

  56. Katsura Y, Ishizawa T, Yoshinaka H et al. Diagnosis of mural invasion and lymph node metastasis of rectal cancer by endorectal ultrasonography. J Jpn Soc Colo-proctl 1990; 43:388–95.

    Article  Google Scholar 

  57. Hildebreandt U, Klein T, Feifel G et al. Endosonography of pararectal lymph nodes: in vitro and in vivo evaluation. Dis Colon Rectum 1990; 33:863–8.

    Article  Google Scholar 

  58. McClave SA, Jones WF, Woolfolk GM et al. Mistakes on EUS staging of colorectal carcinoma: error in interpretation or deception from innate pathologic features? Gastrointest Endosc 2000; 51:682–9.

    Article  PubMed  CAS  Google Scholar 

  59. Goldenberg DM, Goldenberg H, Sharkey RM et al. Clinical studies of cancer radioimmunodetection with carcino-embryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc. Cancer Res 1990; 50:909–121.

    Google Scholar 

  60. Gero EJ, Colcher D, Ferroni P et al. The CA 72–4 radioimmunoassay for the detection of the TAG-72 carcinoma associated antigen in serum of patients. J Clin Lab Analysis 1989; 3:360–9.

    Article  CAS  Google Scholar 

  61. Bischof Delaloye A, Delaloye B, Buchegger F et al. Clinical value of immunoscintigraphy in colorectal carcinoma patients: a prospective study. J Nucl Med 1989; 30:1646–56.

    Google Scholar 

  62. Colcher D, Bird R, Roselli M et al. In vivo tumor targeting of a recombinant single-chain antigen-binding protein. J Natl Cancer Inst 1990;82:1191–7.

    Article  PubMed  CAS  Google Scholar 

  63. Lind P, Leichner P, Arian Schad K et al. Anticarcinoembryonic antigen immunoscintigraphy (Technetium 99m-monoclonal antibody BW 431/26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma. J Nucl Med 1991; 32:1319–25.

    PubMed  CAS  Google Scholar 

  64. Abdel Nabi HH, Schwartz AN, Higano CS et al. Colorectal carcinoma: detection with indium-Ill anticarcinoembryonic-antigen monoclonal antibody ZCE-025. Radiology 1987; 164:617–21.

    Google Scholar 

  65. Doerr RJ, Abdel Nabi H, Krag D et al. Indium 111 ZCE-025 immunoscintigraphy in occult recurrent colorectal cancer with elevated carcinoembryonic antigen level. Arch Surg 1990; 125:226–9.

    Article  PubMed  CAS  Google Scholar 

  66. Bismuth H, Castaing D, Garden OJ The use of operative ultrasound in surgery of primary liver tumors. World J Surg 1987; 11:610–4.

    Article  PubMed  CAS  Google Scholar 

  67. Clarke MP, Kane RA, Steele G Jr et al. Prospective comparison of preoperative imaging and intraoperative ultrasonography in the detection of liver tumors. Surgery 1989; 106:849–55.

    PubMed  CAS  Google Scholar 

  68. Jakimowicz JJ Intraoperative ultrasonography during minimal access surgery. J R Coll Surg 1993; 38:231–8.

    CAS  Google Scholar 

  69. Beynon J, Mortensen NJ Mc, Foy DMA et al. The detection and evaluation of locally recurrent rectal cancer with rectal endosonography. Dis Colon Rectum 1989; 32:509–17.

    Article  PubMed  CAS  Google Scholar 

  70. Huguler M, Houry S Treatment of local recurrence of rectal cancer. Am J Surg 1998; 175:288–92.

    Article  Google Scholar 

  71. Baiter S An introduction to the physics of magnetic resonance imagining. Radiographics 1987;7:371–83.

    Google Scholar 

  72. Blum L, Kressel HY, de Roos A et al. MR imaging differentiation of fibrosis versus recurrent colorectal carcinoma in the pelvis quantitative assessment. Radiology 1988; 169:167.

    Google Scholar 

  73. Beets-Tan RGH, Beets GL, Vligen RFA et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001; 357:497–504.

    Article  PubMed  CAS  Google Scholar 

  74. Moffat FL, Vargas-Cuba RD, Serafini AN et al. Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled Fab’ fragments of IMMU-4 anti-carcinoembryonic antigen monoclonal antibody. Cancer 1994; 73:836–45.

    Article  PubMed  Google Scholar 

  75. Patt YZ, Podoloff DA, Curley S et al. Monoclonal antibody (MoAb) imaging in patients with colorectal cancer with rising serum CFA: experience with ZCE-025 and IMMU-4 MoAb and proposed directions for future clinical trials. Cancer 1993; 71:4293–7.

    Article  PubMed  CAS  Google Scholar 

  76. Mascagni D, Corbellini L, Urciuoli P et al. Endoluminal ultrasound for early detection of local recurrence of rectal cancer. Br J Surg 1989; 76:1176–80.

    Article  PubMed  CAS  Google Scholar 

  77. Romano G, Esercizio L, Santangelo M et al. Impact of computed tomography vs. intrarectal ultrasound on the diagnosis, resecability and prognosis of locally recurrent rectal cancer. Dis Colon Rectum 1993; 36:261–50.

    Article  PubMed  CAS  Google Scholar 

  78. Moh CK, Schiepers C, Seltzer MA et al. PET in oncology: will it replace the other modalities? Semin Nucl Med 1997; 27:94–106.

    Article  Google Scholar 

  79. Gupta N, Bradfield H Role of positron emission tomography scanning in evaluating gastrointestinal neoplasms. Semin Nucl Med 1996; 26:65–73.

    Article  PubMed  CAS  Google Scholar 

  80. Phelps ME, Huang SC, Hoffman EJ et al. Tomographic measurements of local cerebral glucose metabolism in humans with (F-18)-2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979; 6:371–88.

    Article  PubMed  CAS  Google Scholar 

  81. Strauss LG, Conti PS The application of PET in clinical oncology. J Nucl Med 1991; 32:623–48.

    PubMed  CAS  Google Scholar 

  82. Staib L, Schirrmeister H, Reske SN et al. Is 18F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making? Am J Surg 2000; 180:1–5.

    Article  PubMed  CAS  Google Scholar 

  83. Ito M, Takashi K, Tadokoro M et al. Recurrent rectal cancer and scar: differentiation with PET and MR imaging. Radiology 1992; 182:549–52.

    PubMed  CAS  Google Scholar 

  84. Tahara T, Ichiya Y, Kuwabara Y et al. High (18F)-fluorodeoxyglucose uptake in abdominal abscesses: a PET study. J Comput Assist Tomogr 1989; 13:829–31.

    Article  PubMed  CAS  Google Scholar 

  85. Holdeman KP, Mcintosh DG, Smith ML et al. PET imaging of ovarian cancer prior to second look laparotomy. J Nucl Med 1994; 35:117.

    Google Scholar 

  86. Whiteford MH, Whiteford HM, Yee LF et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 2000; 53:759–70.

    Article  Google Scholar 

  87. Johnson K, Bakhsh A, Young D et al. Correlating computed tomography and positron emission tomography scan with operative findings in metastatic colorectal cancer. Dis Colon Rectum 2001; 44:354–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University of Modena and Reggio Emilia, Policlinic, Via del Pozzo 71, 41100, Modena, Italy

    Dr. Maurizio Ponz de Leon

Authors
  1. Dr. Maurizio Ponz de Leon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ponz de Leon, M. (2002). Diagnosis and Clinical Features of Colorectal Cancer. In: Colorectal Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56008-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56008-8_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62762-0

  • Online ISBN: 978-3-642-56008-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation